The blunted response to PA in COPD patients treated with ICS may translate into an absence of recognition of PA by the alveolar macrophages as being detected by a decreased expression of TLR2 and c-jun, which could be one of the mechanisms explaining the increased risk of PA infection in COPD patients. The gene discussed is JUN; the disease is chronic obstructive pulmonary disease.